Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.

Dr Uwe Meya, SynaptixBio’s CMO speaks with Technology Networks, on the challenges of organising, funding, and running clinical trials for rare diseases. Read the full article here...

Expert Insight: The Challenge of Rare Disease Trials | Technology Networks